Pyxis Oncology, Inc. (PYXS) Profit Margin
Pyxis Oncology, Inc. (PYXS) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | -4154.84% |
| 2024-12-31 | -405.47% |
| 2025-12-31 | -484.52% |
How PYXS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc. | -165.60% |
| AQST | Aquestive Therapeutics Inc. | -188.09% |
| VERU | Veru Inc. | -223.86% |
| DYAI | Dyadic International Inc. | -238.31% |
| VSTM | Verastem Inc. | -677.59% |
These are five companies in the same sector as PYXS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Pyxis Oncology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("PYXS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PYXS | $3.37 | +12.71% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 |